Chemopreventive action of diclofenac in dimethybenzanthracene induced lung cancer in female wistar rat

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 29, Issue 3, 2010, Pages 255-265

  Thakur, Poonam ^a   Sanyal, S N ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apoptosis; COX 2; Diclofenac; Lung cancer

Indexed keywords

CYCLOOXYGENASE 2; DICLOFENAC; DIMETHYLBENZ[A]ANTHRACENE; SODIUM CHLORIDE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME INHIBITION; FEMALE; FLUORESCENCE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG CANCER; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LUNG; LUNG TUMOR; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS NORVEGICUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CYCLOOXYGENASE 2; DICLOFENAC; FEMALE; LUNG; LUNG NEOPLASMS; RATS; RATS, WISTAR;

EID: 79953018887     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v29.i3.80     Document Type: Article

References (42)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
2. Wynder EL. Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res. 1994;54:5284-95.
3. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health. 1997;50:307-64.
4. Buters J, Martinez LQ, Schober W, Soballa VJ, Hintermair J, Wolff T, Gonzalez FJ, Greim H. CYP1B1 determines susceptibility to low doses of 7, 12-dimethylbenz[a]anthracene induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis. 2003;24:327-34.
5. Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Chi H, Chen J, Huang MT, Yang CS. Inhibition of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2003;23:1307-13.
6. Kleiner HE, Vulimiri SV, Reed M, Uberecken A, Di- Giovanni J. Role of cytochrome P450 1A1 and 1B1 in the metabolic activation of 7,12-dimethylbenz[a]- anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem Res Toxicol. 2003;15:226-35.
7. Weimer TL, Reddy AP, Harttig U, Alexander D, Stamm SC, Miller MR, Baird W, Hendricks J, Bailey G. Influence of beta-Naphtoflavone on 7,12-Dimethybenz(a)anthracene metabolism, DNA adduction and tumorigenicity in rainbow trout. Toxicol Sci. 2000;57:217-28.
8. Castelao JE, Bart RD, DiPerna CA, Sievers EM, Bremner RM. Lung cancer and cyclooxygenase-2. Ann Thorac Surg. 2003;76:1327-35.
9. Bauer AK, Nield LDD, Malkinson AM. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 2000;21 (4):543-55.
10. Wiese FW, Thompson PA, Kadlubar FF. Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis. 2001;22:5-10.
11. Gridelli C, Maione P, Airoma G, Rossi A. Selective cylooxygenase 2 inhibitors and non-small cell lung cancer. Curr Med Chem. 2002;9:1851-8.
12. Hirsch FR, Lippman SM. Advances in the biology of lung cancer chemoprevention. J Clin Oncol. 2005;23(14):3186-97.
13. Hilario MOE, Terreri MT, Len CA. Nonsteroidal anti -inflammatory drugs: cyclooxyenase 2 inhibitors. J Pediatr (Rio J). 2006;82(5):S206-12.
14. Asgari M, White E, Chren MM. Nonsteroidal antiinflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg. 2004;30:1335-42.
15. James DS. The multisystem adverse effects of NSAID therapy. J Am Osteopath Assoc. 1999;99(11):S1-7.
16. Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase 2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst. 2006;98(11):736-47.
17. Giuliano F, Warner TD. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal antiinflammatory drugs. Br J Pharmacol. 1999;126:1824-30.
18. Kam PCA, See AUL. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia. 2000;55:442-49.
19. Schultz S, Lagasse CA, Odell KM. Cyclooxygenase 2 (COX 2) selective non-steroidal anti-inflammatory drugs-clinical implications of cardiovascular outcomes. J Air Force Pharm. 2005;12(1):8-19.
20. Thakur P, Sanyal SN. Chemopreventive role of preferential COX-2 inhibitor diclofenac in 9, 10- dimethybenz(a)anthracene induced experimental lung carcinogenesis. Am J Biomed Sci. 2010;2(3):275-88.
21. Thakur P, Sanyal SN. Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 Dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac. Exp Mol Pathol. 2010; 88:394-400.
22. Saini RK, Sanyal SN. Pulmonary carcinogenesis in mice with a single intratracheal instillation of 9,10- Dimethyl Benz(a)anthracene. Drug Chem Toxicol. 2008;31:459-71.
23. Kaur J, Sanyal SN. Association of PI3-kinase and Wnt signaling in non-steroidal anti-inflammatory drug-induced apoptosis in experimental colon cancer. Am J Biomed Sci. 2009;1(4):395-405.
24. Pearse AGE. In: Histochemistry theoretical and applied. 3rd ed. Vol. 1. Churchill Livingstone (London);1968;p 660.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989;p-192.
26. Schwartz LM, Osborne BA. Cell Death. Method Cell Biol. 1995;46:15-8.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein- dye binding. Anal Biochem. 1976;72:248-54.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4.
29. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 1979;47:5590-4.
30. Boyde TRC, Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetylmonoxime. Anal Biochem. 1980;107:424-31.
31. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics. CA Cancer J Clin. 2003;53:5-26.
32. Riedl K, Krysan K, Põld M, Dalwadi H, Vourc'h NH, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updates. 2004;7(3):169-84.
33. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci. 2003;24(2):96-102.
34. Bauers AK, Nield LDD, Malkinson AM. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 2000;21(4):543-50.
35. Zhu YM, Azahri NSM, Yu DCW, Woll PJ. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer. 2008;8(218):1471-240.
36. Cho M, Gwak J, Park S, Won J, Kim DE, Yea SS, Cha IJ, Kim TK, Shin JG, Oh S. Diclofenac attenuates Wnt/β-catenin signaling in colon cancer cells by activation of NF-κB. FEBS Letters. 2005;579:4213-18.
37. Chang HC, Weng CF. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Oncol Res. 2001;8:1321-5.
38. Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol. 2005;23(5):953-64.
39. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-45.
40. Eifuku R, Yoshimatsu T, Yoshino I, Takenoyama M, Imahayashi S, So T, Hanagiri T, Nomoto K, Yasumoto K. Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-γ. Jpn J Clin Oncol. 2000;30:295-300.
41. Malkinson AM. Role of inflammation in mouse lung tumorigenesis: a review. Exp Lung Res. 2005;31:57-82.
42. Fujimoto H, Ando Y, Yamashita T, Terazaki H, Tanaka Y, Sasaki M, Suga M, Ando M. Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res. 1997;88:1190-8.